Home Healthcare Biotechnology Companion Diagnostics for Oncology Market

Companion Diagnostics for Oncology Market Size, Share & Trends Analysis Report By Products and Services (Assays, Kits, and Reagents, Software and Services), By Technology (Polymerase Chain Reaction (PCR), Next-Generation Sequencing (NGS)), By Indication (Breast Cancer, Lung Cancer, Colorectal Cancer, Gastric Cancer, Melanoma, Others), By End-User (Pharmaceutical and Biopharmaceutical Companies, Laboratories, Contract Research Organizations, Others) and By Region (North America, Europe, APAC, Middle East and Africa, LATAM) Forecasts, 2026-2034

Last Updated: June 03, 2026 | Author: Debashree B | Format: | Report Code: SR3513DR | Pages: 110
Overview TOC Segmentation Methodology
Download Free Sample

Market Segmentation

  1. Companion Diagnostics for Oncology Market, By Products and Services 2022-2034 (USD MILLION/ Units)
    1. Assays, Kits, and Reagents
    2. Software and Services
  2. Companion Diagnostics for Oncology Market, By Technology 2022-2034 (USD MILLION/ Units)
    1. Polymerase Chain Reaction (PCR)
    2. Next-Generation Sequencing (NGS)
  3. Companion Diagnostics for Oncology Market, By Indication 2022-2034 (USD MILLION/ Units)
    1. Breast Cancer
    2. Lung Cancer
    3. Colorectal Cancer
    4. Gastric Cancer
    5. Melanoma
    6. Others
  4. Companion Diagnostics for Oncology Market, By End-User 2022-2034 (USD MILLION/ Units)
    1. Pharmaceutical and Biopharmaceutical Companies
    2. Laboratories
    3. Contract Research Organizations
    4. Others
  5. Regional Companion Diagnostics for Oncology Market
    1. North America
      1. North America Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      2. North America Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      3. North America Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      4. North America Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
      5. U.S. Companion Diagnostics for Oncology Market
        1. U.S. Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. U.S. Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. U.S. Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. U.S. Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      6. Canada Companion Diagnostics for Oncology Market
        1. Canada Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Canada Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Canada Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Canada Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
    2. Europe
      1. Europe Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      2. Europe Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      3. Europe Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      4. Europe Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
      5. U.K. Companion Diagnostics for Oncology Market
        1. U.K. Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. U.K. Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. U.K. Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. U.K. Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      6. Germany Companion Diagnostics for Oncology Market
        1. Germany Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Germany Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Germany Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Germany Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      7. France Companion Diagnostics for Oncology Market
        1. France Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. France Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. France Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. France Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      8. Spain Companion Diagnostics for Oncology Market
        1. Spain Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Spain Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Spain Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Spain Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      9. Italy Companion Diagnostics for Oncology Market
        1. Italy Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Italy Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Italy Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Italy Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      10. Russia Companion Diagnostics for Oncology Market
        1. Russia Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Russia Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Russia Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Russia Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      11. Nordic Companion Diagnostics for Oncology Market
        1. Nordic Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Nordic Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Nordic Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Nordic Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      12. Benelux Companion Diagnostics for Oncology Market
        1. Benelux Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Benelux Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Benelux Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Benelux Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      13. Rest of Europe Companion Diagnostics for Oncology Market
        1. Rest of Europe Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Rest of Europe Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Rest of Europe Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Rest of Europe Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
    3. APAC
      1. APAC Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      2. APAC Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      3. APAC Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      4. APAC Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
      5. China Companion Diagnostics for Oncology Market
        1. China Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. China Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. China Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. China Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      6. Korea Companion Diagnostics for Oncology Market
        1. Korea Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Korea Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Korea Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Korea Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      7. Japan Companion Diagnostics for Oncology Market
        1. Japan Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Japan Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Japan Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Japan Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      8. India Companion Diagnostics for Oncology Market
        1. India Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. India Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. India Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. India Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      9. Australia Companion Diagnostics for Oncology Market
        1. Australia Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Australia Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Australia Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Australia Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      10. Taiwan Companion Diagnostics for Oncology Market
        1. Taiwan Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Taiwan Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Taiwan Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Taiwan Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      11. South East Asia Companion Diagnostics for Oncology Market
        1. South East Asia Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. South East Asia Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. South East Asia Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. South East Asia Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      12. Rest of Asia-Pacific Companion Diagnostics for Oncology Market
        1. Rest of Asia-Pacific Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Rest of Asia-Pacific Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Rest of Asia-Pacific Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Rest of Asia-Pacific Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
    4. Middle East and Africa
      1. Middle East and Africa Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      2. Middle East and Africa Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      3. Middle East and Africa Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      4. Middle East and Africa Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
      5. UAE Companion Diagnostics for Oncology Market
        1. UAE Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. UAE Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. UAE Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. UAE Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      6. Turkey Companion Diagnostics for Oncology Market
        1. Turkey Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Turkey Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Turkey Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Turkey Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      7. Saudi Arabia Companion Diagnostics for Oncology Market
        1. Saudi Arabia Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Saudi Arabia Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Saudi Arabia Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Saudi Arabia Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      8. South Africa Companion Diagnostics for Oncology Market
        1. South Africa Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. South Africa Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. South Africa Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. South Africa Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      9. Egypt Companion Diagnostics for Oncology Market
        1. Egypt Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Egypt Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Egypt Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Egypt Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      10. Nigeria Companion Diagnostics for Oncology Market
        1. Nigeria Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Nigeria Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Nigeria Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Nigeria Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      11. Rest of MEA Companion Diagnostics for Oncology Market
        1. Rest of MEA Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Rest of MEA Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Rest of MEA Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Rest of MEA Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
    5. LATAM
      1. LATAM Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
        1. Assays, Kits, and Reagents
        2. Software and Services
      2. LATAM Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
        1. Polymerase Chain Reaction (PCR)
        2. Next-Generation Sequencing (NGS)
      3. LATAM Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
        1. Breast Cancer
        2. Lung Cancer
        3. Colorectal Cancer
        4. Gastric Cancer
        5. Melanoma
        6. Others
      4. LATAM Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
        1. Pharmaceutical and Biopharmaceutical Companies
        2. Laboratories
        3. Contract Research Organizations
        4. Others
      5. Brazil Companion Diagnostics for Oncology Market
        1. Brazil Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Brazil Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Brazil Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Brazil Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      6. Mexico Companion Diagnostics for Oncology Market
        1. Mexico Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Mexico Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Mexico Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Mexico Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      7. Argentina Companion Diagnostics for Oncology Market
        1. Argentina Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Argentina Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Argentina Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Argentina Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      8. Chile Companion Diagnostics for Oncology Market
        1. Chile Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Chile Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Chile Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Chile Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      9. Colombia Companion Diagnostics for Oncology Market
        1. Colombia Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Colombia Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Colombia Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Colombia Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
      10. Rest of LATAM Companion Diagnostics for Oncology Market
        1. Rest of LATAM Companion Diagnostics for Oncology Market By Products and Services 2022-2034 (USD MILLION/ Units)
          1. Assays, Kits, and Reagents
          2. Software and Services
        2. Rest of LATAM Companion Diagnostics for Oncology Market By Technology 2022-2034 (USD MILLION/ Units)
          1. Polymerase Chain Reaction (PCR)
          2. Next-Generation Sequencing (NGS)
        3. Rest of LATAM Companion Diagnostics for Oncology Market By Indication 2022-2034 (USD MILLION/ Units)
          1. Breast Cancer
          2. Lung Cancer
          3. Colorectal Cancer
          4. Gastric Cancer
          5. Melanoma
          6. Others
        4. Rest of LATAM Companion Diagnostics for Oncology Market By End-User 2022-2034 (USD MILLION/ Units)
          1. Pharmaceutical and Biopharmaceutical Companies
          2. Laboratories
          3. Contract Research Organizations
          4. Others
200+ Trusted Partners
LG Electronics AMCAD Engineering KOBE STEEL LTD. Hindustan National Glass & Industries Limited Voith Group International Paper Hansol Paper Whirlpool Corporation Sony Samsung Electronics Qualcomm Google Fiserv Veto-Pharma Nippon Becton Dickinson Merck Argon Medical Devices Abbott Ajinomoto Denon Doosan Meiji Seika Kaisha Ltd LG Chemicals LCY chemical group Bayer Airrane BASF Toyota Industries Nissan Motors Neenah Mitsubishi Hyundai Motor Company Honda CRP Industries Inc pewag LGE Panasonic Lubrizol Corporation Leonardo Johnson & Johnson HB Fuller MITSUBISHI CHEMICAL Hyundai Mobis Amazon
Download Free Sample
Reach out to us
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)
sales@straitsresearch.com

We are featured on:

Straits Research
Address:
105, Panchshil The Golden Bell,
Koregaon Park Annexe, Mundhwa,
Pune, Maharashtra 411036
Contact Us:
+1 646 905 0080 (U.S.)
+91 8087085354 (India)
+44 203 695 0070 (U.K.)

sales@straitsresearch.com

Quick Links
Help
Verified. Protected. Secure.
Duns
DMCA.com Protection Status
lets-encrypt
Secure Payments:
Secure Payments
Follow Us:
www.straitsresearch.com © Copyright . All rights Reserved.